Login / Signup

Ionic Liquid-Based Immunization Patch for the Transdermal Delivery of Antigens.

Rashedul IslamFahmida Habib NabilaRie WakabayashiYoshirou KawaguchiNoriho KamiyaMuhammad MoniruzzamanMasahiro Goto
Published in: Molecules (Basel, Switzerland) (2024)
Herein, we report a transdermal patch prepared using an ionic liquid-based solid in oil (IL-S/O) nanodispersion and a pressure-sensitive adhesive (PSA) to deliver the macromolecular antigenic protein, ovalbumin (OVA). The IL-S/O nanodispersion and a PSA were first mixed at an equal weight ratio, then coated onto a release liner, and covered with a support film. To evaluate the effect of the PSA, three types of PSAs, DURO-TAK 87-4098, DURO-TAK 87-4287, and DURO-TAK 87-235A, were used to obtain the corresponding IL-S/O patches SP-4098, SP-4287, and SP-235A, respectively. The prepared IL-S/O patches were characterized for surface morphology, viscoelasticity, and moisture content. In vitro skin penetration and in vivo immunization studies of the IL-S/O patches were performed using Yucatan micropig skin and the C57BL/6NJc1 mice model, respectively. The SP-4098 and SP-4287 delivered 5.49-fold and 5.47-fold higher amounts of drug compared with the aqueous formulation. Although both patches delivered a similar amount of drug, SP-4287 was not detached fully from the release liner after 30 days, indicating low stability. Mice immunized with the OVA-containing SP-4098 produced a 10-fold increase in anti-OVA IgG compared with those treated with an aqueous formulation. These findings suggested that the IL-S/O patch may be a good platform for the transdermal delivery of antigen molecules.
Keyphrases
  • ionic liquid
  • prostate cancer
  • room temperature
  • radical prostatectomy
  • weight loss
  • soft tissue
  • dendritic cells
  • adipose tissue
  • high throughput
  • drug induced
  • amino acid
  • newly diagnosed
  • weight gain
  • adverse drug